Molson Coors downgraded, GM upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.

Top 5 Upgrades:

• Barclays upgraded General Motors (GM) to Overweight from Equal Weight with a price target of $73, up from $55. The firm sees a favorable environment for the company amid easing U.S. electric vehicle regulations and “resiliency” in U.S. car pricing.
• Rothschild & Co Redburn upgraded FactSet (FDS) to Neutral from Sell with a price target of $370, down from $415. The firm believes the shares are pricing in the downside risk after underperforming year-to-date.
• UBS upgraded Alaska Air (ALK) to Buy from Neutral with a price target of $90, up from $56. The firm believes the consensus estimates do not fully reflect the potential contribution from Alaska Air’s initiatives going forward.
• Barclays upgraded Aptiv (APTV) to Overweight from Equal Weight with a price target of $105, up from $85. The shares have rallied recently due to favorable end market data points and improved market sentiment, but there is more upside ahead, the firm tells investors in a research note.
• Argus upgraded Air Products (APD) to Buy from Hold. The near environment has been challenging with industrial demand weakness and high input costs, but conditions are beginning to change, the firm tells investors in a research note.

Top 5 Downgrades:

• Barclays downgraded Constellation Brands (STZ) to Equal Weight from Overweight with a price target of $150, down from $202. The firm is challenged to find a near-term catalyst for beer trends and downgraded Constellation as a result.
• Barclays downgraded Molson Coors (TAP) to Underweight from Equal Weight with a price target of $50, up from $49. The firm believes beer category trends and investor sentiment “are likely to be weighed down for some time.”
• Telsey Advisory downgraded RH (RH) to Market Perform from Outperform with a price target of $220, down from $255, following last night’s earnings report. The firm cites the company’s reduced revenue and profit outlook, due to a delay in a Sourcebook mailing and higher costs as a result of recently enacted tariffs, for the downgrade.
• Argus downgraded J.M. Smucker (SJM) to Hold from Buy with no price target. While the company is working to offset commodity inflation and supply-chain challenges with price hikes and improved productivity, the price hikes are further pressuring volume, Argus states.
• Goldman Sachs downgraded Novartis (NVS) to Sell from Neutral with a price target of $118, down from $119. Novartis has been the best performing stocks in European pharma over the last five years, but its growth rate will “structurally reset lower,” the firm tells investors in a research note.

Top 5 Initiations:

• Oppenheimer analyst Rayna Kumar assumed coverage of Circle Internet (CRCL) with a Perform rating. While Oppenheimer believes Circle is unique among competition, it remains on the sidelines, considering that the stock is trading 331% above its IPO price and 65x FY26 EBITDA.
• Roth Capital initiated coverage of Sportradar (SRAD) with a Buy rating and $40 price target. The firm likes the company’s “leading position in the fast-growing” sports data and technology services sector.
• Roth Capital initiated coverage of Genius Sports (GENI) with a Buy rating and $16 price target. The firm views Genius Sports as an attractive growth story with four-year estimated revenue and adjusted EBITDA CAGR’s through 2028 off 19% and 36%, respectively, and a relatively consistent beat-and-raise track record.
• Stephens resumed coverage of Limoneira (LMNR) with an Equal Weight rating and $18 price target. With the company undergoing a strategic transformation, divesting from lemon-heavy operations and partnering with Sunkist to streamline citrus marketing and reduce overhead, the firm recommends waiting on the sidelines until there is greater visibility into the company’s ability to unlock its cash flow potential with an earnings inflection unlikely before FY27.
• Goldman Sachs reinstated coverage of LPL Financial (LPLA) with a Buy rating and $405 price target, which represents 18% upside. The firm believes near-term earnings dilution from the Commonwealth Financial Network acquisition deal, LPL’s recently slower new assets growth, and earnings headwinds from lower interest rates are now “heavily discounted” in the shares.